Jupiter Neurosciences, Inc. is a clinical-stage drug platform company focused on treating neuroinflammation, specifically targeting Alzheimer’s disease and rare neurological disorders. The company is developing JOTROL™, an oral medication designed to address these conditions safely and effectively. Jupiter aims to improve patient outcomes with innovative therapies that bypass common side effects associated with similar treatments. The company’s scientific advisory team brings specialized expertise in neurological diseases and drug development. Jupiter collaborates with industry leaders and organizations to advance its mission of creating impactful treatments that address critical needs in the field of neuroinflammation and cognitive health.